Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Karolinska's Axelar comes up short in Phase II with lung cancer drug
Karolinska's Axelar comes up short in Phase II with lung cancer drug
Karolinska's Axelar comes up short in Phase II with lung cancer drug
Submitted by
admin
on December 30, 2013 - 5:45pm
Source:
Fierce Biotech
News Tags:
Axelar
AXL1717
non-small cell lung cancer
Headline:
Karolinska's Axelar comes up short in Phase II with lung cancer drug
Do Not Allow Advertisers to Use My Personal information
